QA: Emergent Biosolutions Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367644_2024_Emergent_Biosolutions_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 183.08771929824562, 'aggregate_val': 1049300000, 'exp_sum': 5700000, 'exp_to_value': {'remainder_Revenues': 5700000}}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 1043600000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}
warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 1.313475997686524, 'aggregate_val': 1200000000, 'exp_sum': 518700000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 308000000, 'ResearchAndDevelopmentExpense': 70700000, 'remainder_Expenses': 140000000}}

Graph

Absolute values for 0001367644, Emergent Biosolutions Inc

  xvar xval
0 AssetsCurrent 679,500,000
1 IntangibleAssetsNetIncludingGoodwill 566,600,000
2 PropertyPlantAndEquipmentNet 382,800,000
3 remainder_Assets 194,300,000
4 LiabilitiesCurrent 651,300,000
5 LiabilitiesNoncurrent 475,400,000
6 remainder_Liabilities 47,200,000
7 CostOfGoodsAndServicesSold 702,140,069
8 SellingGeneralAndAdministrativeExpense 376,195,333
9 ResearchAndDevelopmentExpense 100,708,883
10 remainder_Expenses 314,821,522
11 remainder_Revenues 1,028,335,759
12 remainder_NetIncome -13,015,249
13 remainder_ComprehensiveNetIncome -2,773,475
  yvar yval
0 Assets 1,823,200,000
1 Liabilities 1,173,900,000
2 Expenses 1,493,865,807
3 Revenues 1,028,335,759
4 StockholdersEquity 649,300,000
5 NetIncome -478,545,297
6 ComprehensiveNetIncome -479,932,034
7 BaseVar 2,767,545,145
8 EconomicCapitalRatiobeforeLimitedLiability 0.624
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time